| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/02/2009 | WO2009041626A1 Reagent kit for sample analysis and sample analysis method |
| 04/02/2009 | WO2009041577A1 Urine pretreatment agent for urinary protein determination, urine pretreatment method, and urinary protein determination method |
| 04/02/2009 | WO2009041501A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | WO2009041113A1 NK CELL HAVING Fc RECEPTOR GENE INTRODUCED THEREIN, METHOD FOR PRODUCTION OF THE SAME, AND METHOD FOR ASSAY ON ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY USING THE SAME |
| 04/02/2009 | WO2009041035A1 Measuring method using biosensor |
| 04/02/2009 | WO2009040789A2 T cell subpopulations capable of treating cancer |
| 04/02/2009 | WO2009040782A2 A method of assessing colorectal cancer status in an individual |
| 04/02/2009 | WO2009040746A1 Sensor device for the detection of target components |
| 04/02/2009 | WO2009040721A1 A microelectronic sensor device comprising a carrier with electrical conductors |
| 04/02/2009 | WO2009040674A2 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 04/02/2009 | WO2009040641A1 Gas sensor fitting structure |
| 04/02/2009 | WO2009040635A1 Device and method for detecting degradation of fuel for internal combustion engine |
| 04/02/2009 | WO2009040563A1 Tagging method |
| 04/02/2009 | WO2009040534A1 Diagnostic method |
| 04/02/2009 | WO2009040508A2 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 04/02/2009 | WO2009040451A1 Method of immunological analysis for detection of antibodies against human gstt1 (anti-hgstt1) |
| 04/02/2009 | WO2009040409A1 Drug monitoring assay |
| 04/02/2009 | WO2009040400A1 Means and methods for the detection of contrast medium-induced nephrotoxicity |
| 04/02/2009 | WO2009040377A2 Radiolabelled 1, 4 -dihydro-4 -oxo-quinoline 3-carboxylic acid derivatives for pet and spect imaging, and in-vitro detection of the gaba-a receptor |
| 04/02/2009 | WO2009040364A1 Multiparameter assay |
| 04/02/2009 | WO2009040133A1 Osteopontin as novel prognostic biomarker for heart failure |
| 04/02/2009 | WO2009040114A2 Compounds and markers for surface-enhanced raman scattering |
| 04/02/2009 | WO2009039945A1 Electrochemical antioxidant sensors based on metallic oxide modified electrodes for the generation of hydroxyl radicals and the subsequent measurement of antioxidant activities |
| 04/02/2009 | WO2009039920A1 Arrangement, method, and sensor for detecting fluid parameters |
| 04/02/2009 | WO2009039854A2 Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| 04/02/2009 | WO2009039720A1 A slide cup of cells or bacteria with a spacer |
| 04/02/2009 | WO2009039584A1 Diagnosis and treatment of diseased and damaged tissue |
| 04/02/2009 | WO2009039542A2 Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak |
| 04/02/2009 | WO2009021971A3 Novel targets and compounds for therapeutic intervention of hiv infection |
| 04/02/2009 | WO2009021908A3 Disposable enzymatic sensor for liquid samples |
| 04/02/2009 | WO2009020782A3 Oral fluid assays for the detection of heavy metal exposure |
| 04/02/2009 | WO2009019458A3 Erythropoietin fusion proteins |
| 04/02/2009 | WO2009014700A3 Analyte collection devices and methods |
| 04/02/2009 | WO2009013538A3 Glycosylation markers for cancer and chronic inflammation |
| 04/02/2009 | WO2009012220A3 Analyte detection assays |
| 04/02/2009 | WO2009010656A3 Device for controlling the immersion of probes and/or sensors measuring the physico-chemical parameters of liquids, and associated measuring system |
| 04/02/2009 | WO2009007412A3 Age deglycation |
| 04/02/2009 | WO2009007042A3 Device for providing gases, in particular for isotopic ratio analysis |
| 04/02/2009 | WO2009006990A3 Minor splicosome assay system for modulating cell division |
| 04/02/2009 | WO2009006643A9 Measurement of protein using inclusion body dry weight |
| 04/02/2009 | WO2009004494A3 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 04/02/2009 | WO2008157299A3 Differential expression profiling analysis of cell culture phenotypes and uses thereof |
| 04/02/2009 | WO2008150565A3 Ranolazine for elevated brain-type natriuretic peptide |
| 04/02/2009 | WO2008141282A3 Materials and methods for foxp3 tumor suppression |
| 04/02/2009 | WO2008132464A3 Mek5 and related proteins as biomarkers of neurodegenerative diseases |
| 04/02/2009 | WO2008124647A3 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 04/02/2009 | WO2008120006A3 Diagnostic assay |
| 04/02/2009 | WO2008118390A3 Biomarkers for diagnostic and therapeutic methods |
| 04/02/2009 | WO2008117027A3 Altered mitochondrial activity in diseases resulting from oxidative stress |
| 04/02/2009 | WO2008110777A3 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 04/02/2009 | WO2008099419A3 Autoantibodies for protein antigens as markers for cancer of gingivo-buccal complex |
| 04/02/2009 | WO2008095462A4 Device and method for detecting the wear of an implant material and correspondingly produced implant |
| 04/02/2009 | WO2008077958A3 Soluble urokinase plasminogen activator receptor (supar) as marker for diseases |
| 04/02/2009 | WO2008073627A3 Method of diagnosing and treating asthma |
| 04/02/2009 | WO2008071910A3 Cytokeratin acetylation and detection of hdac5 |
| 04/02/2009 | WO2008054881A3 Antibacterial and plasmid elimination agents |
| 04/02/2009 | WO2008048614A9 Methods and targets for identifying materials for regulating hyper-proliferative skin conditions |
| 04/02/2009 | WO2008041953A3 Dengue diagnosis and treatment |
| 04/02/2009 | WO2008036328A3 A method and kit for detecting s-nitrosothiol reduction of s-nitrosylated proteins |
| 04/02/2009 | WO2008021183A3 For the identification, assessment, and treatment of patients with cancer therapy |
| 04/02/2009 | WO2008020013A3 Methods and means for determining platelet function and diagnosing platelet- related and cardiovascular disorders |
| 04/02/2009 | WO2007101225A3 Methods to identify inhibitors of the unfolded protein response |
| 04/02/2009 | WO2006096185A3 Reagentless and reusable biosensors with tunable differential binding affinites and methods of making |
| 04/02/2009 | WO2006076100A3 Tubulin isotype screening in cancer therapy using halichondrin b analogs |
| 04/02/2009 | WO2006063133A3 Biomarker for inflammatory bowel disease |
| 04/02/2009 | WO2006042146A3 Multifunctional nanoparticles conjugates and their use |
| 04/02/2009 | WO2006036848A3 Multiple bead reagent system for protein based assays with optimized matrices |
| 04/02/2009 | WO2006028585A3 Optical fiber bundle for detecting binding of chemical species |
| 04/02/2009 | WO2006017728A3 Apparatus and method for measuring concentrations of molecules through a barrier |
| 04/02/2009 | WO2005117930A3 Use of thioredoxin measurements for diagnostics and treatments |
| 04/02/2009 | WO2005097169A3 Novel immunotherapy |
| 04/02/2009 | WO2005096730A3 Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds |
| 04/02/2009 | WO2005084193A3 Method for identifying a site of protein-protein interaction for the rational design of short peptides that interfere with that interaction |
| 04/02/2009 | WO2005081908A3 Reagents, kits and methods for immunodetection of epitopes on molecules |
| 04/02/2009 | WO2005076984A3 Thymidylate synthase gene and metastasis |
| 04/02/2009 | WO2005076891A3 Cell proliferation associated with ccx ckr expression |
| 04/02/2009 | WO2005062982A3 Signal amplification methods for analyte detection |
| 04/02/2009 | WO2005059507A3 Biosensor and method of making same |
| 04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 04/02/2009 | WO2005047861A3 Device for analyte measurement |
| 04/02/2009 | WO2005047853A3 Apparatus and method for detecting an analyte |
| 04/02/2009 | WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2005013081A3 Methods and systems for applying genetic operators to determine system conditions |
| 04/02/2009 | WO2005002416A3 Predictors of renal disease |
| 04/02/2009 | WO2005001060A3 Novel calcium channel |
| 04/02/2009 | WO2004069859A3 Restoring function to gonadotropin releasing hormone receptor mutants |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | WO2003012026A8 Apparatus and method for determining the onset and presence of sepsis conditions |
| 04/02/2009 | US20090089891 Transcription factor stress-related proteins and methods of use in plants |
| 04/02/2009 | US20090089888 Sour/Acid Taste Receptors Assays, Genes and Proteins |
| 04/02/2009 | US20090089010 System and method for determining an abused sensor during analyte measurement |
| 04/02/2009 | US20090088985 Method and Apparatus for Measuring the Conductivity of the Water Fraction of a Wet Gas |
| 04/02/2009 | US20090088984 Copper contamination detection method and system for monitoring copper contamination |
| 04/02/2009 | US20090088982 Co-detection of single polypeptide and polynucleotide molecules |
| 04/02/2009 | US20090088657 Sensor for measuring carbon dioxide in respiratory gas |
| 04/02/2009 | US20090088563 Consisting of a sense and antisense region that form a duplex region; and from zero to one overhang regions; gene silencing, gene expression inhibition; gene therapy, drug discovery; cancer, Alzheimer's disease, diabetes |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |